Update: 10.12.2024
Last week: 47 week 2024 (25.11.2024 - 01.12.2024)
Last full month: November 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 874 | -2.7% | 13.6% | 0.3 | 18 202 033 | -0.2% | 9.4% | 0.3 | -4.9% |
| MoM | 44 632 | -3.6% | 13.3% | -0.2 | 78 965 673 | 0.5% | 8.9% | 0.2 | -2.0% |
| YTD | 384 777 | 23.0% | 12.2% | 3.1 | 768 837 868 | 28.7% | 9.3% | 1.7 | -8.7% |
| MAT | 412 738 | 22.7% | 12.0% | 3 | 828 401 559 | 29.6% | 9.2% | 1.6 | -7.6% |
| BRAINMAX | |||||||||
| WoW | 2 393 | -7.5% | 100.0% | 0 | 7 953 975 | -8.3% | 100.0% | 0 | -7.5% |
| MoM | 11 703 | 2.1% | 100.0% | 0 | 38 888 035 | -0.2% | 100.0% | 0 | 2.1% |
| YTD | 73 353 | 75.5% | 100.0% | 0 | 254 797 804 | 77.2% | 100.0% | 0 | 75.5% |
| MAT | 78 212 | 77.4% | 100.0% | 0 | 271 979 355 | 79.9% | 100.0% | 0 | 77.4% |
| GOLDLINE PLUS | |||||||||
| WoW | 13 809 | -1.8% | 47.5% | 1.4 | 42 776 996 | -2.2% | 38.6% | 1.4 | -4.5% |
| MoM | 62 745 | -4.1% | 47.4% | 1.3 | 195 756 051 | -3.4% | 38.7% | 0.9 | -6.7% |
| YTD | 774 330 | -4.7% | 45.3% | 0.5 | 2 429 642 536 | -3.2% | 37.1% | -2.6 | -5.8% |
| MAT | 830 552 | -3.7% | 45.4% | 0.6 | 2 612 458 988 | -1.5% | 37.2% | -2.4 | -5.0% |
| MIGRENIUM | |||||||||
| WoW | 8 876 | 0.9% | 0.4% | 0 | 3 040 979 | 1.7% | 0.5% | 0 | -0.9% |
| MoM | 41 128 | 0.4% | 0.4% | 0 | 14 076 174 | 0.9% | 0.6% | 0.1 | -9.7% |
| YTD | 534 246 | -10.7% | 0.5% | -0.1 | 169 914 346 | 50.8% | 0.7% | 0.2 | 5.4% |
| MAT | 577 420 | -11.9% | 0.5% | -0.1 | 179 872 667 | 46.4% | 0.6% | 0.1 | 6.7% |
| MODELAX-N | |||||||||
| WoW | 28 027 | 4.3% | 20.8% | 0.8 | 13 983 262 | 5.9% | 14.1% | 0.9 | 0.1% |
| MoM | 119 981 | 0.2% | 20.6% | 0.4 | 59 442 550 | 4.1% | 13.8% | 0.6 | -2.0% |
| YTD | 1 357 483 | 25.9% | 22.0% | 3.2 | 605 363 946 | 73.3% | 14.3% | 3.8 | 7.8% |
| MAT | 1 446 914 | 27.0% | 21.5% | 3 | 638 877 536 | 72.8% | 13.9% | 3.6 | 9.2% |
| REDUXIN | |||||||||
| WoW | 9 222 | -7.4% | 31.7% | -1 | 48 401 011 | -9.0% | 43.7% | -1.5 | -4.5% |
| MoM | 41 852 | -9.0% | 31.6% | -0.8 | 222 036 149 | -6.5% | 43.9% | -0.4 | -6.7% |
| YTD | 558 438 | -6.9% | 32.7% | -0.4 | 2 963 323 101 | 10.7% | 45.2% | 2.9 | -5.8% |
| MAT | 596 382 | -6.4% | 32.6% | -0.5 | 3 159 674 280 | 11.9% | 45.0% | 2.8 | -5.0% |
| REDUXIN FORTE | |||||||||
| WoW | 2 726 | -3.2% | 9.4% | 0.1 | 12 077 859 | -0.9% | 10.9% | 0.5 | -4.5% |
| MoM | 12 608 | -9.7% | 9.5% | -0.3 | 53 587 719 | -9.2% | 10.6% | -0.4 | -6.7% |
| YTD | 156 070 | 0.8% | 9.1% | 0.6 | 671 418 487 | 11.1% | 10.3% | 0.7 | -5.8% |
| MAT | 167 258 | 1.2% | 9.1% | 0.6 | 720 725 857 | 11.9% | 10.3% | 0.6 | -5.0% |
| SALVISAR | |||||||||
| WoW | 12 968 | -12.7% | 1.8% | -0.2 | 5 789 246 | -12.3% | 1.7% | -0.1 | -4.9% |
| MoM | 65 206 | 11.6% | 2.0% | 0.3 | 28 985 629 | 13.4% | 1.8% | 0.3 | -7.2% |
| YTD | 519 207 | 11.9% | 1.5% | 0.2 | 217 133 397 | 42.4% | 1.3% | 0.3 | -3.2% |
| MAT | 553 434 | 7.1% | 1.4% | 0.1 | 228 415 294 | 33.9% | 1.3% | 0.2 | -1.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 384 777 | 23.0% | 12.2% | 3.1 | 768 837 868 | 28.7% | 9.3% | 1.7 | -8.7% |
| BRAINMAX | 73 353 | 75.5% | 100.0% | 0 | 254 797 804 | 77.2% | 100.0% | 0 | 75.5% |
| GOLDLINE PLUS | 774 330 | -4.7% | 45.3% | 0.5 | 2 429 642 536 | -3.2% | 37.1% | -2.6 | -5.8% |
| MIGRENIUM | 534 246 | -10.7% | 0.5% | -0.1 | 169 914 346 | 50.8% | 0.7% | 0.2 | 5.4% |
| MODELAX-N | 1 357 483 | 25.9% | 22.0% | 3.2 | 605 363 946 | 73.3% | 14.3% | 3.8 | 7.8% |
| REDUXIN CAPS | 558 438 | -6.9% | 32.7% | -0.4 | 2 963 323 101 | 10.7% | 45.2% | 2.9 | -5.8% |
| REDUXIN FORTE | 156 070 | 0.8% | 9.1% | 0.6 | 671 418 487 | 11.1% | 10.3% | 0.7 | -5.8% |
| SALVISAR | 519 207 | 11.9% | 1.5% | 0.2 | 217 133 397 | 42.4% | 1.3% | 0.3 | -3.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 412 738 | 22.7% | 12.0% | 3 | 828 401 559 | 29.6% | 9.2% | 1.6 | -7.6% |
| BRAINMAX | 78 212 | 77.4% | 100.0% | 0 | 271 979 355 | 79.9% | 100.0% | 0 | 77.4% |
| GOLDLINE PLUS | 830 552 | -3.7% | 45.4% | 0.6 | 2 612 458 988 | -1.5% | 37.2% | -2.4 | -5.0% |
| MIGRENIUM | 577 420 | -11.9% | 0.5% | -0.1 | 179 872 667 | 46.4% | 0.6% | 0.1 | 6.7% |
| MODELAX-N | 1 446 914 | 27.0% | 21.5% | 3 | 638 877 536 | 72.8% | 13.9% | 3.6 | 9.2% |
| REDUXIN CAPS | 596 382 | -6.4% | 32.6% | -0.5 | 3 159 674 280 | 11.9% | 45.0% | 2.8 | -5.0% |
| REDUXIN FORTE | 167 258 | 1.2% | 9.1% | 0.6 | 720 725 857 | 11.9% | 10.3% | 0.6 | -5.0% |
| SALVISAR | 553 434 | 7.1% | 1.4% | 0.1 | 228 415 294 | 33.9% | 1.3% | 0.2 | -1.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 874 | -2.7% | 13.6% | 0.3 | 18 202 033 | -0.2% | 9.4% | 0.3 | -4.9% |
| BRAINMAX | 2 393 | -7.5% | 100.0% | 0 | 7 953 975 | -8.3% | 100.0% | 0 | -7.5% |
| GOLDLINE PLUS | 13 809 | -1.8% | 47.5% | 1.4 | 42 776 996 | -2.2% | 38.6% | 1.4 | -4.5% |
| MIGRENIUM | 8 876 | 0.9% | 0.4% | 0 | 3 040 979 | 1.7% | 0.5% | 0 | -0.9% |
| MODELAX-N | 28 027 | 4.3% | 20.8% | 0.8 | 13 983 262 | 5.9% | 14.1% | 0.9 | 0.1% |
| REDUXIN CAPS | 9 222 | -7.4% | 31.7% | -1 | 48 401 011 | -9.0% | 43.7% | -1.5 | -4.5% |
| REDUXIN FORTE | 2 726 | -3.2% | 9.4% | 0.1 | 12 077 859 | -0.9% | 10.9% | 0.5 | -4.5% |
| SALVISAR | 12 968 | -12.7% | 1.8% | -0.2 | 5 789 246 | -12.3% | 1.7% | -0.1 | -4.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 44 632 | -3.6% | 13.3% | -0.2 | 78 965 673 | 0.5% | 8.9% | 0.2 | -2.0% |
| BRAINMAX | 11 703 | 2.1% | 100.0% | 0 | 38 888 035 | -0.2% | 100.0% | 0 | 2.1% |
| GOLDLINE PLUS | 62 745 | -4.1% | 47.4% | 1.3 | 195 756 051 | -3.4% | 38.7% | 0.9 | -6.7% |
| MIGRENIUM | 41 128 | 0.4% | 0.4% | 0 | 14 076 174 | 0.9% | 0.6% | 0.1 | -9.7% |
| MODELAX-N | 119 981 | 0.2% | 20.6% | 0.4 | 59 442 550 | 4.1% | 13.8% | 0.6 | -2.0% |
| REDUXIN CAPS | 41 852 | -9.0% | 31.6% | -0.8 | 222 036 149 | -6.5% | 43.9% | -0.4 | -6.7% |
| REDUXIN FORTE | 12 608 | -9.7% | 9.5% | -0.3 | 53 587 719 | -9.2% | 10.6% | -0.4 | -6.7% |
| SALVISAR | 65 206 | 11.6% | 2.0% | 0.3 | 28 985 629 | 13.4% | 1.8% | 0.3 | -7.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
*****
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs